| Ytd | ||
| 1y |
| Open | 0.20 | Prev Close | 0.20 | Low | 0.20 | High | 0.20 | Mkt Cap | 9.52M |
| Vol | 5.95M | Avg Vol | 0.00 | EPS | N/A | P/E | N/A | Forward P/E | -3.26 |
| Beta | 1.57 | Short Ratio | 0.32 | Inst. Own | 81.19% | Dividend | 1.69 | Div Yield | 840.47 |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | N/A | 200-d Avg | N/A | 1yr Est | 9.19 |
EPIX News
SOUTH SAN FRANCISCO, Calif., USA and VANCOUVER, BC, Canada , Oct. 9, 2025 /PRNewswire/ - ESSA Pharma
SOUTH SAN FRANCISCO, USA and VANCOUVER, Canada , Oct. 6, 2025 /PRNewswire/ - ESSA Pharma Inc. (NASDA
ESSA Pharma Inc. (NASDAQ:EPIX ) Shareholder/Analyst Call October 3, 2025 5:00 PM EDT Company Partici
SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC , Sept.
Shareholders expected to receive approximately $0.12 per share in cash upon closing of transaction a
Adjournment to provide time for continued discussions regarding possible revised financial terms of
SOUTH SAN FRANCISCO, Calif and VANCOUVER, BC , Aug. 25, 2025 /PRNewswire/ -- ESSA Pharma Inc. ("ESSA
SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC , Aug. 14, 2025 /PRNewswire/ -- ESSA Pharma Inc. ("ESS
SOUTH SAN FRANCISCO, Calif and VANCOUVER, Canada , Aug. 6, 2025 /PRNewswire/ -- ESSA Pharma Inc. ("E
SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC , July 23, 2025 /PRNewswire/ -- ESSA Pharma Inc. ("ESS
NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t
SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC and BOSTON and EMERYVILLE, Calif.
Company continues to explore and review strategic options focused on maximizing shareholder value SO
NEW YORK, NY / ACCESS Newswire / March 25, 2025 / If you suffered a loss on your ESSA Pharma Inc. (N
NEW YORK , March 25, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ESSA Pharma In
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a share
NEW YORK, NY / ACCESS Newswire / March 25, 2025 / If you suffered a loss on your ESSA Pharma Inc. (N
NEW YORK, NY / ACCESS Newswire / March 25, 2025 / WHY: Rosen Law Firm, a global investor rights law
NEW YORK, NY / ACCESS Newswire / March 25, 2025 / If you suffered a loss on your ESSA Pharma Inc. (N
U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday.
U.S. stock futures were lower this morning, with the Nasdaq futures falling around 100 points on Tue
Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gain
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on M
Gainers 1847 Holdings LLC (NASDAQ: EFSH) shares surged 72.7% to $3.25 after the company reported
Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday afte
During Monday's trading, 528 companies set new 52-week lows.
On Thursday, 1076 companies hit new 52-week lows.
On Tuesday, 507 stocks hit new 52-week lows.
During Friday's session, 574 stocks hit new 52-week lows.
On Tuesday, 400 companies set new 52-week lows.
On Tuesday, 186 companies set new 52-week lows.
On Wednesday, 193 stocks hit new 52-week lows.
On Friday, 319 stocks hit new 52-week lows.
On Thursday, 588 stocks hit new 52-week lows.